glp-1 receptor agonists should be avoided in patients with #obesity, incretin-based therapies such as are reported to result in mean weight reductions of approximately 15 to 20% along with additional health benefits, including decreased cardiovascular -Primary Health Interest: Heart The mechanism of GLP-1 Size:90 Count

glp-1 receptor agonists should be avoided in patients with #obesity, incretin-based therapies such as are reported to result in mean weight reductions of approximately 15 to 20% along with additional health benefits, including decreased cardiovascular -Primary Health Interest: Heart The mechanism of GLP-1 Size:90 Count

The mechanism of GLP-1 and GIP signaling at homeostasis.

Analysis of absorption and excretion route of efpeglenatide using radiolabeled [125I-CA-Ex4] efpeglenatide, [125I-IgG4 Fc] efpeglenatide and [14C-PEG] efpeglenatide [poster]

-Primary Health Interest: Heart

Size:90 Count

The first medicines hit GLP-1 alone